Financials
- Market Capitalization 27.35 B
- Employee 100
- Founded 1996
- CEO N/A
- Website www.royaltypharma.com
- Headquarter United Kingdom
- FIGI N/A
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
29.98
Relación precio/flujo de caja
12.37
Dividendos por acción
0.47
Rendimiento por dividendo, %
4
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 352 | RVMD Revolution Medicines, Inc. - Common Stock | 203.39 USD | -2.16% | -2.89% | +10.28% | +267.13% | 43.59 B USD | ||
| 436 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 240.14 USD | +1.28% | +3.69% | +15.43% | -46.14% | 32.13 B USD | ||
| 500 | INSM Insmed Incorporated - Common Stock | 120.44 USD | +1.60% | -2.99% | +22.65% | -25.68% | 26.30 B USD | ||
| 511 | ROIV Roivant Sciences Ltd. - Common Shares | 34.16 USD | -1.58% | -5.87% | +2.95% | +86.56% | 24.67 B USD |